Barclays PLC Grows Holdings in GoHealth, Inc. (NASDAQ:GOCO)

Barclays PLC increased its position in shares of GoHealth, Inc. (NASDAQ:GOCO) by 83.9% during the 3rd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 9,580 shares of the company’s stock after buying an additional 4,372 shares during the period. Barclays PLC’s holdings in GoHealth were worth $89,000 at the end of the most recent quarter.

Several other institutional investors have also recently made changes to their positions in the company. Geode Capital Management LLC increased its stake in shares of GoHealth by 3.2% during the third quarter. Geode Capital Management LLC now owns 103,735 shares of the company’s stock valued at $973,000 after buying an additional 3,205 shares during the period. Empowered Funds LLC grew its stake in GoHealth by 5.1% in the third quarter. Empowered Funds LLC now owns 22,048 shares of the company’s stock valued at $207,000 after purchasing an additional 1,072 shares during the last quarter. Renaissance Technologies LLC grew its stake in GoHealth by 22.0% in the second quarter. Renaissance Technologies LLC now owns 18,272 shares of the company’s stock valued at $178,000 after purchasing an additional 3,300 shares during the last quarter. Finally, Bank of New York Mellon Corp grew its stake in GoHealth by 16.1% in the second quarter. Bank of New York Mellon Corp now owns 12,982 shares of the company’s stock valued at $126,000 after purchasing an additional 1,802 shares during the last quarter. Hedge funds and other institutional investors own 24.21% of the company’s stock.

GoHealth Price Performance

Shares of GOCO stock opened at $17.73 on Friday. GoHealth, Inc. has a fifty-two week low of $7.27 and a fifty-two week high of $17.83. The firm has a market capitalization of $406.19 million, a price-to-earnings ratio of -5.07 and a beta of 1.64. The company has a debt-to-equity ratio of 1.72, a quick ratio of 1.18 and a current ratio of 1.18. The stock’s 50-day simple moving average is $12.72 and its 200-day simple moving average is $11.17.

GoHealth (NASDAQ:GOCO) last issued its earnings results on Thursday, November 7th. The company reported ($3.73) EPS for the quarter, missing analysts’ consensus estimates of ($3.19) by ($0.54). The firm had revenue of $118.29 million during the quarter, compared to analysts’ expectations of $105.93 million. GoHealth had a negative net margin of 4.32% and a negative return on equity of 17.17%. During the same quarter in the prior year, the company earned ($2.61) EPS. As a group, equities analysts forecast that GoHealth, Inc. will post -5.5 earnings per share for the current fiscal year.

Wall Street Analyst Weigh In

Separately, Royal Bank of Canada restated a “sector perform” rating and set a $13.00 price target on shares of GoHealth in a research note on Monday, October 21st.

GoHealth Company Profile

GoHealth, Inc operates as a health insurance marketplace and Medicare-focused digital health company in the United States. The company operates a technology platform that leverages machine-learning algorithms of insurance behavioral data to optimize the process for helping individuals find the health insurance plan for their specific needs.